Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €75.70 EUR
Change Today +0.50 / 0.67%
Volume 0.0
WMD On Other Exchanges
As of 6:32 AM 09/2/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Lynn Seely M.D.

Chief Medical Officer,Medivation, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

As of Fiscal Year 2014


Dr. Lynn Seely, M.D. has been the Chief Medical Officer of Medivation, Inc. (Formerly Orion Acquisition Corp. II) since May 9, 2005. Dr. Seely is responsible for the strategy and execution of Orion Acquisition Corp. II's clinical development programs, and for assisting in the evaluation of new opportunities to expand. Dr. Seely served as Vice President of Clinical Development at Corgentech Inc., from 2002 to 2005, At Corgentech, Dr. Seely was responsible for all aspects ...

Read Full Background

Corporate Headquarters*

525 Market Street
San Francisco, California 94105

United States

Phone: 415-543-3470
Fax: 415-543-3411

Board Members Memberships*

There is no Board Members Memberships data available.


Oklahoma City University
College of Medicine at the University of Oklahoma

Other Affiliations*

Annual Compensation*

Total Annual Compensation$500,000

Stock Options*

Restricted Stock Awards$536,060
All Other Compensation$13,356
Exercised Options240,686
Exercised Options Value$19,822,385
Exercisable Options318,360
Exercisable Options Value$25,525,853
Unexercisable Options89,354
Unexercisable Options Value$3,728,053
Total Value of Options$49,076,291
Total Number of Options648,400

Total Compensation*

Total Annual Cash Compensation$1,158,356
Total Short Term Compensation$500,000
Other Long Term Compensation$549,416
Total Calculated Compensation$3,501,462
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
WMD:GR €75.70 EUR +0.50


Harvey J. Berger M.D.Principal Founder, Chairman, Chief Executive Officer and President
Ariad Pharmaceuticals Inc.
Clay B. Siegall Ph.D.Co-Founder, Chairman, Chief Executive Officer and President
Seattle Genetics, Inc.
Shailesh Ayyangar B.V.Fc & A.H., P.G.D.M.Managing Director, Vice President of South Asia, Global Operations, Executive Director, Member of Audit Committee and Member of Corporate Social Responsibility Committee
Sanofi India Limited
Aijaz Tobaccowalla Managing Director, Director, Member of Board Administrative & Share Transfer Committee, Member of Nomination & Remuneration Committee, Member of Corporate Social Responsibility Committee and Member of Audit Committee
Pfizer Limited
Michael L. Babich Chief Executive Officer, President and Director
INSYS Therapeutics, Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDIVATION INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at